Search Results - "OMLAND, TORBJØRN"

Cardio-Protective Therapy in Cardio-Oncology: Quo Vadis? by Omland, Torbjørn

Get full text

Targeting the endothelin system: a step towards a precision medicine approach in heart failure with preserved ejection fraction? by Omland, Torbjørn

“…Abstract…”
Get full text

Can Circulating B-Type Natriuretic Peptide Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease? by Omland, Torbjørn

Get full text

Cardiac Troponin Increase After Endurance Exercise: A New Marker of Cardiovascular Risk? by Omland, Torbjørn, Aakre, Kristin Moberg

Get full text

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity by Omland, Torbjørn, Heck, Siri Lagethon, Gulati, Geeta

“…Cardiotoxicity is a relatively frequent and potentially serious side effect of traditional and targeted cancer therapies. Both general measures and specific…”
Get full text

A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics by Lyngbakken, Magnus Nakrem, Berdal, Jan-Erik, Eskesen, Arne, Kvale, Dag, Olsen, Inge Christoffer, Rueegg, Corina Silvia, Rangberg, Anbjørg, Jonassen, Christine Monceyron, Omland, Torbjørn, Røsjø, Helge, Dalgard, Olav

“…Here, we randomized 53 patients hospitalized with coronavirus disease 2019 (COVID-19) to hydroxychloroquine therapy (at a dose of 400 mg twice daily for seven…”
Get full text

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Plasma Is Associated With Intensive Care Unit Admission and Mortality in Patients Hospitalized With Coronavirus Disease 2019 by Prebensen, Christian, Myhre, Peder L, Jonassen, Christine, Rangberg, Anbjørg, Blomfeldt, Anita, Svensson, My, Omland, Torbjørn, Berdal, Jan-Erik

“…The clinical significance of severe acute respiratory syndrome coronavirus 2 RNA in the circulation is unknown. In this prospective cohort study, we detected…”
Get full text

Novel biomarkers of cardiovascular disease: Applications in clinical practice by Lyngbakken, Magnus Nakrem, Myhre, Peder Langeland, Røsjø, Helge, Omland, Torbjørn

“…Measurement of biomarkers has revolutionized the work-up of patients with suspected cardiovascular disease. The most widely used contemporary cardiovascular…”
Get full text

Fine-Tuning Risk Stratification in Heart Failure by Myhre, Peder L., Omland, Torbjørn

Get full text

Physical activity, exercise and cardiac troponins: Clinical implications by Aakre, Kristin M., Omland, Torbjørn

“…Cardiac troponins constitute essential components of the cardiac contractile apparatus and are released into the bloodstream following cardiomyocyte injury…”
Get full text

Sex-Based Differences in Cardiometabolic Biomarkers by Lew, Jeanney, Sanghavi, Monika, Ayers, Colby R, McGuire, Darren K, Omland, Torbjørn, Atzler, Dorothee, Gore, Maria O, Neeland, Ian, Berry, Jarett D, Khera, Amit, Rohatgi, Anand, de Lemos, James A

“…Few data are available comparing cardiovascular disease (CVD) biomarker profiles between women and men in the general population. We analyzed sex-based…”
Get full text

Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure by Omland, Torbjørn

“…BACKGROUND:Circulating concentrations of B-type natriuretic peptide (BNP) and the aminoterminal fragment (NT-proBNP) of its prohormone (proBNP) are increased…”
Get full text

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease? by Omland, Torbjørn

Get full text

Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome by Tveit, Sjur H., Myhre, Peder L., Hanssen, Tove Aminda, Forsdahl, Signe Helene, Iqbal, Amjid, Omland, Torbjørn, Schirmer, Henrik

“…To compare the performance of high-sensitivity cardiac troponin I and T (hs-cTnI; hs-cTnT) in diagnosing obstructive coronary artery disease (CAD 50 ) in…”
Get full text

Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction by Mills, Nicholas L, Omland, Torbjørn

Get full text

State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease by Omland, Torbjørn, White, Harvey D

“…Multiple circulating biomarkers have been associated with the incidence of cardiovascular events and proposed as potential tools for risk stratification in…”
Get full text

Circulating microRNAs predict future fatal myocardial infarction in healthy individuals – The HUNT study by Bye, Anja, Røsjø, Helge, Nauman, Javaid, Silva, Gustavo J.J, Follestad, Turid, Omland, Torbjørn, Wisløff, Ulrik

“…Abstract Coronary heart disease is the most common cause of death, and the number of individuals at risk is increasing. To better manage this pandemic,…”
Get full text

The rise and fall of the 99th percentile decision limit for cardiac troponins? by Aakre, Kristin Moberg, Omland, Torbjørn

Get full text

Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers by Aakre, Kristin M, Saenger, Amy K, Body, Rick, Collinson, Paul, Hammarsten, Ola, Jaffe, Allan S, Kavsak, Pete, Omland, Torbjørn, Ordonez-Lianos, Jordi, Apple, Fred S

“…Abstract The International Federation of Clinical Chemistry Committee on Clinical Application of Cardiac Bio-Markers provides evidence-based educational…”
Get full text

Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more by Magliocca, Aurora, Omland, Torbjørn, Latini, Roberto

Get full text